Bionime is committed to sustainable ESG development. We firmly believe that a company’s success lies not only in product excellence but also in environmental protection, social contribution, and good governance. We leverage advanced technologies to improve resource efficiency and promote green energy and low-carbon emissions. We are also actively involved in social welfare initiatives, promoting fairness and harmony in society. In governance, we adhere to the highest standards, ensuring transparency and accountability. We believe that intelligent management and sustainable practices will guide us toward a brighter future.
Environmental Protection
Environmental stewardship is a fundamental pillar of Bionime Corporation’s corporate strategy. We integrate ESG principles throughout our research and development, manufacturing, and business operations, driving sustainability initiatives including greenhouse gas (GHG) inventories, product carbon footprint management, and energy management. These initiatives are designed to minimize environmental impact while enhancing resource efficiency.
Since 2023, we have conducted annual greenhouse gas inventories verified by independent third parties. In 2025, we further strengthened our sustainability efforts by implementing an ISO 50001 Energy Management System and obtaining certification. Through continuous optimization of energy-intensive equipment and the implementation of energy-saving measures, we are committed to reducing carbon emissions and advancing steadily toward our net-zero and sustainable development objectives.
2.15%
Energy Saving
Rate
632,341kWh
Solar Power
Generation
97.5%
Scrap Material
Recycling Rate
Green Vision, Sustainable Commitment
Climate change and the greenhouse effect are critical issues that we must confront. Bionime is actively promoting energy conservation, carbon reduction, and environmental protection strategies. We are committed to improving energy efficiency to ensure the sustainable coexistence of our business operations and the planet.
Green Product Design
Bionime incorporates green design principles into the development of its next-generation CGM transmitter platform and integrated CGM product architecture. Sustainability considerations are embedded throughout the entire product life cycle, from raw material selection and product design to manufacturing, packaging, and logistics. By continuously improving manufacturability and production yield, optimizing resource efficiency, reducing energy consumption during product use, and lowering manufacturing-related carbon emissions, we strive to develop innovative healthcare solutions that deliver both environmental and long-term sustainable value.
Automated Machines
Bionime is dedicated to independently developing automated production equipment and has been recognized by CommonWealth Magazine as the only biotech and medical company in Taiwan to achieve Industry 3.0-level automation or above. We are actively advancing toward Industry 4.0 standards to further enhance energy efficiency and reduce carbon emissions.
Carbon Management
Bionime has passed external verification for ISO 14064 greenhouse gas inventory and is continuously implementing ISO 14067 for product carbon footprint. We are also launching a series of sustainability-related initiatives moving forward.
Social Responsibility
Guided by its vision of “Creating Medical Monitoring Solutions People Can Trust,” Bionime Corporation is committed to its core values of Integrity, Innovation, Excellence, and Customer Satisfaction. The Company also embraces the United Nations Sustainable Development Goals (SDGs) as an important framework for advancing its long-term sustainability strategy.
As part of its commitment to corporate social responsibility, Bionime leverages its expertise in blood glucose monitoring to promote public health through a variety of initiatives, including the donation of blood glucose meters and test strips, public health education programs, and community blood glucose screening activities. These efforts help enhance public awareness of diabetes prevention and health management.
In addition, Bionime continues to support the development of Taiwan’s biotechnology innovation ecosystem. As of the end of 2025, the Company had invested in one domestic innovative startup, BONRAYBIO CO., LTD. (TWSE Innovation Board: 6955), with an outstanding investment balance of NT$188 million. Through these investments, Bionime actively supports innovative research and development while fostering the sustainable growth of the biotechnology industry.
63%
Female Employee Ratio
25.6%
The proportion of
female executives
76.9 %
Parental leave
return-to-work rate
Diverse Workplace, Sustainable Health
Bionime regularly conducts employee health check-ups and occupational safety and health training courses. We have also established an on-site health center and nursing room within our facilities. In addition, we employ occupational safety personnel, nurses, and on-site physicians to provide a safe and supportive working environment for our employees.
Maternity Protection
Bionime places great emphasis on supporting pregnant employees by implementing the following protective measures: hazard identification and risk assessment related to pregnancy, adjustments to job responsibilities, prohibition from working in harmful environments, regular consultations with on-site physicians, and the issuance of maternity rights cards to ensure the protection of pregnant employees’ rights. Additional support includes designated parking spaces for expectant mothers and the provision of nursing and lactation rooms.
Employee Protection
We have obtained ISO 45001 Occupational Health and Safety Management System certification and implement the following employee protection measures to provide a safe working environment: regular hazard identification and risk assessments, emergency response drills, control of hazardous chemicals by managing them from the source, implementation of workplace environmental monitoring, and occupational health and safety education and training.
Workplace Diversity
Bionime provides job opportunities for underrepresented groups, including individuals with disabilities, Indigenous peoples, and second-time job seekers, promoting diversity in employment. We are committed to ensuring fairness in compensation and career advancement, and we strictly prohibit discrimination, harassment, or unequal treatment based on race, gender, religious beliefs, age, political affiliation, or any other status protected by applicable laws.
Corporate Governance
Good corporate governance is the core of Bionime’s long-term value creation. We uphold transparency, accountability, and ethical standards to ensure operations align with legal, ethical, and social responsibility frameworks.
To ensure operational efficiency and transparency, we are committed to implementing the highest standards of governance practices. We have established robust internal controls and a risk management framework to ensure the accuracy and transparency of financial reporting. We prioritize shareholder interests, maintain open and transparent communication with shareholders, and actively respond to their concerns and expectations.
75 hours
Total hours of continuing education
for directors and supervisors
33 %
Proportion of female board members
Integrity in Governance, Sustainability in Operations
Bionime is committed to a business philosophy of integrity, transparency, and accountability. We have established integrity-based policies and built sound corporate governance and risk management mechanisms to create a sustainable business environment.
Cybersecurity Measures
Certified in international standards including ISO/IEC 27001, 27701, 27017, and 27018, we strengthen information security and personal data protection. We have implemented data leakage prevention mechanisms and conduct regular training to ensure system backup and incident response capabilities. This enables us to continuously safeguard the information assets of the company and our customers, ensuring the effective operation of our cybersecurity management system.
Corporate Mission
Bionime’s corporate mission is to create blood glucose meters that users can trust and use with confidence. To achieve this mission, we provide precise and accurate testing results through unique product designs, creating a satisfying and trustworthy user experience that brings better health to more people.
Supplier Management
We establish relevant codes of conduct with our supply chain partners, requiring compliance with laws and regulations related to environmental protection, occupational safety and health, and labor rights. At the same time, we value collaborative growth with our suppliers, uphold the belief in mutual prosperity, prioritize local sourcing, and integrate the spirit of sustainability into the daily management of our supply chain.
Strive for Excellence,
Pursue Innovation and Change
Bionime controls the entire process from research and development to production. Our blood glucose meters (BGM) feature patented nano-scale precious metal electrodes, achieving high accuracy.
Our uniquely designed continuous glucose monitoring system (CGM) effectively resist interference and present blood glucose data as continuous “dynamic glucose fluctuation curves,” enabling users to monitor their glucose levels in real time without interruption.
The company develops new products rapidly, with all products protected by patents. Through continuous improvements in quality, yield, processes, and cost, we strive to surpass ourselves and pursue excellence, aiming to become a leading innovator in the industry.
Intelligent Management, Sustainable Business Practices
Careers
Contact
Environmental Protection
Environmental stewardship is a fundamental pillar of Bionime Corporation’s corporate strategy. We integrate ESG principles throughout our research and development, manufacturing, and business operations, driving sustainability initiatives including greenhouse gas (GHG) inventories, product carbon footprint management, and energy management. These initiatives are designed to minimize environmental impact while enhancing resource efficiency.
Since 2023, we have conducted annual greenhouse gas inventories verified by independent third parties. In 2025, we further strengthened our sustainability efforts by implementing an ISO 50001 Energy Management System and obtaining certification. Through continuous optimization of energy-intensive equipment and the implementation of energy-saving measures, we are committed to reducing carbon emissions and advancing steadily toward our net-zero and sustainable development objectives.
2.15%
632,341kWh
97.5%
Energy Saving
Rate
Solar Power
Generation
Scrap Material
Recycling Rate
Green Vision, Sustainable Commitment
Climate change and the greenhouse effect are critical issues that we must confront. Bionime is actively promoting energy conservation, carbon reduction, and environmental protection strategies. We are committed to improving energy efficiency to ensure the sustainable coexistence of our business operations and the planet.
Green Product Design
Bionime incorporates green design principles into the development of its next-generation CGM transmitter platform and integrated CGM product architecture. Sustainability considerations are embedded throughout the entire product life cycle, from raw material selection and product design to manufacturing, packaging, and logistics. By continuously improving manufacturability and production yield, optimizing resource efficiency, reducing energy consumption during product use, and lowering manufacturing-related carbon emissions, we strive to develop innovative healthcare solutions that deliver both environmental and long-term sustainable value.
Automated Machines
Bionime is dedicated to independently developing automated production equipment and has been recognized by CommonWealth Magazine as the only biotech and medical company in Taiwan to achieve Industry 3.0-level automation or above. We are actively advancing toward Industry 4.0 standards to further enhance energy efficiency and reduce carbon emissions.
Carbon Management
Bionime has passed external verification for ISO 14064 greenhouse gas inventory and is continuously implementing ISO 14067 for product carbon footprint. We are also launching a series of sustainability-related initiatives moving forward.
Social Responsibility
Guided by its vision of “Creating Medical Monitoring Solutions People Can Trust,” Bionime Corporation is committed to its core values of Integrity, Innovation, Excellence, and Customer Satisfaction. The Company also embraces the United Nations Sustainable Development Goals (SDGs) as an important framework for advancing its long-term sustainability strategy.
As part of its commitment to corporate social responsibility, Bionime leverages its expertise in blood glucose monitoring to promote public health through a variety of initiatives, including the donation of blood glucose meters and test strips, public health education programs, and community blood glucose screening activities. These efforts help enhance public awareness of diabetes prevention and health management.
In addition, Bionime continues to support the development of Taiwan’s biotechnology innovation ecosystem. As of the end of 2025, the Company had invested in one domestic innovative startup, BONRAYBIO CO., LTD. (TWSE Innovation Board: 6955), with an outstanding investment balance of NT$188 million. Through these investments, Bionime actively supports innovative research and development while fostering the sustainable growth of the biotechnology industry.
63%
25.6%
76.9%
Female Employee Ratio
The proportion of
female executives
Parental leave
return-to-work rate
Diverse Workplace, Sustainable Health
Bionime regularly conducts employee health check-ups and occupational safety and health training courses. We have also established an on-site health center and nursing room within our facilities. In addition, we employ occupational safety personnel, nurses, and on-site physicians to provide a safe and supportive working environment for our employees.
Maternity Protection
Bionime places great emphasis on supporting pregnant employees by implementing the following protective measures: hazard identification and risk assessment related to pregnancy, adjustments to job responsibilities, prohibition from working in harmful environments, regular consultations with on-site physicians, and the issuance of maternity rights cards to ensure the protection of pregnant employees’ rights. Additional support includes designated parking spaces for expectant mothers and the provision of nursing and lactation rooms.
Employee Protection
We have obtained ISO 45001 Occupational Health and Safety Management System certification and implement the following employee protection measures to provide a safe working environment: regular hazard identification and risk assessments, emergency response drills, control of hazardous chemicals by managing them from the source, implementation of workplace environmental monitoring, and occupational health and safety education and training.
Workplace Diversity
Bionime provides job opportunities for underrepresented groups, including individuals with disabilities, Indigenous peoples, and second-time job seekers, promoting diversity in employment. We are committed to ensuring fairness in compensation and career advancement, and we strictly prohibit discrimination, harassment, or unequal treatment based on race, gender, religious beliefs, age, political affiliation, or any other status protected by applicable laws.
Corporate Governance
Good corporate governance is the core of Bionime’s long-term value creation. We uphold transparency, accountability, and ethical standards to ensure operations align with legal, ethical, and social responsibility frameworks.
To ensure operational efficiency and transparency, we are committed to implementing the highest standards of governance practices. We have established robust internal controls and a risk management framework to ensure the accuracy and transparency of financial reporting. We prioritize shareholder interests, maintain open and transparent communication with shareholders, and actively respond to their concerns and expectations.
75hours
33%
Total hours of continuing education
for directors and supervisors
Proportion of female board members
Integrity in Governance, Sustainability in Operations
Bionime is committed to a business philosophy of integrity, transparency, and accountability. We have established integrity-based policies and built sound corporate governance and risk management mechanisms to create a sustainable business environment.
Cybersecurity Measures
Certified in international standards including ISO/IEC 27001, 27701, 27017, and 27018, we strengthen information security and personal data protection. We have implemented data leakage prevention mechanisms and conduct regular training to ensure system backup and incident response capabilities. This enables us to continuously safeguard the information assets of the company and our customers, ensuring the effective operation of our cybersecurity management system.
Corporate Mission
Bionime’s corporate mission is to create blood glucose meters that users can trust and use with confidence. To achieve this mission, we provide precise and accurate testing results through unique product designs, creating a satisfying and trustworthy user experience that brings better health to more people.
Supplier Management
We establish relevant codes of conduct with our supply chain partners, requiring compliance with laws and regulations related to environmental protection, occupational safety and health, and labor rights. At the same time, we value collaborative growth with our suppliers, uphold the belief in mutual prosperity, prioritize local sourcing, and integrate the spirit of sustainability into the daily management of our supply chain.
Strive for Excellence,
Pursue Innovation
and Change
Bionime controls the entire process from research and development to production. Our blood glucose meters (BGM) feature patented nano-scale precious metal electrodes, achieving high accuracy.
Our uniquely designed continuous glucose monitoring system (CGM) effectively resist interference and present blood glucose data as continuous “dynamic glucose fluctuation curves,” enabling users to monitor their glucose levels in real time without interruption.
The company develops new products rapidly, with all products protected by patents. Through continuous improvements in quality, yield, processes, and cost, we strive to surpass ourselves and pursue excellence, aiming to become a leading innovator in the industry.
Intelligent Management,
Sustainable Business Practices
